• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE Back to Search Results
Model Number SGC0701
Device Problem Off-Label Use (1494)
Patient Problem Thrombosis (2100)
Event Date 08/20/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).The customer reported the device is not returning.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.The additional device is filed under a separate medwatch report number.
 
Event Description
This is filed to report thrombus.It was reported that this was a mitraclip procedure to treat tricuspid regurgitation (tr) with a grade of 4+.The clip delivery system (cds) was inserted; however, before the clip exited the steerable guide catheter (sgc), a large thrombus was noticed on the tip of the sgc.It was noted that the activated clotting time (act) remain above 250 throughout the procedure.The cds was removed; however, once the clip was removed, thrombus was noticed all around the clip.Aspiration was them performed, but it was then noted that the sgc had thrombus inside the clear chamber.A 16fr sheath was inserted and additional heparin was administered while removing the sgc.The thrombus had been resolved; therefore, a new sgc and cds were inserted without issues.The clip was successfully implanted, reducing tr to a grade of 1-2.There was no clinically significant delay in the procedure.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.It should be noted that the mitraclip instructions for use (ifu) states: the mitraclip g4 system is indicated for the percutaneous reduction of significant symptomatic mitral regurgitation.Based on the information reviewed, the reported off-label use of the device was associated with the procedure being performed on the tricuspid valve; however, in this case, it cannot be determined if the off-label use contributed to the reported thrombus.A cause for the thrombus could not be determined in this case; however, thrombosis is listed in the mitraclip ifu as a known possible complication associated with mitraclip procedures.There is no indication of a product issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G4 STEERABLE GUIDING CATHETER
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10515287
MDR Text Key206349053
Report Number2024168-2020-07545
Device Sequence Number1
Product Code DRA
UDI-Device Identifier08717648231025
UDI-Public08717648231025
Combination Product (y/n)N
PMA/PMN Number
K190167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/10/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/25/2021
Device Model NumberSGC0701
Device Catalogue NumberSGC0701
Device Lot Number00623U601
Was Device Available for Evaluation? No
Date Manufacturer Received10/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CLIP DELIVERY SYSTEM; CLIP DELIVERY SYSTEM
Patient Outcome(s) Required Intervention;
-
-